Definitive Healthcare (NASDAQ:DH) Cut to Neutral at BTIG Research
BTIG Research lowered shares of Definitive Healthcare (NASDAQ:DH – Free Report) from a buy rating to a neutral rating in a report released on Friday, MarketBeat.com reports. Several other equities research analysts have also issued reports on DH. Barclays dropped their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating […]
BTIG Research lowered shares of Definitive Healthcare (NASDAQ:DH – Free Report) from a buy rating to a neutral rating in a report released on Friday, MarketBeat.com reports. Several other equities research analysts have also issued reports on DH. Barclays dropped their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating […]
